Future Fertility is a company dedicated to revolutionizing oocyte assessment with the power of artificial intelligence. Their advanced AI-powered tools leverage the industry's largest and most diverse image dataset to provide an objective and reliable methodology for evaluating oocyte quality.

Future Fertility aims to improve patient counseling and fertility treatment decisions by offering personalized and clear egg quality insights. Their award-winning egg quality reports, such as VIOLET™ and MAGENTA™, empower patients and clinics worldwide to make more informed and personalized decisions along the fertility journey.

The company collaborates with leading fertility clinics globally, with their assessments used in over 180 clinics across 32 countries. Their tools are clinically validated, backed by scientific research, and published in peer-reviewed journals, emphasizing their commitment to advancing fertility care.

Future Fertility's non-invasive tools integrate seamlessly into clinic workflows, enabling standardization and delivering objective insights that enhance treatment planning and research. Their innovative approach facilitates a higher level of scientific research and personalized treatment options, contributing significantly to the field of reproductive medicine.